With approximately $103 billion in brand-name medications losing patent exclusivity by the end of the decade, there's tremendous savings potential for health plans and employers. And with biosimilars soon to enter the market, along with a looming expected increase in specialty pharmacy costs, the time is now for health plans and employers to get their generic promotion strategies in place.

Benefit Design Tools to Take Full Advantage of the Wave of Generic Drugs provides a slew of benefit design tactics to increase generic utilization, including:

  • Implementing value-based benefit designs;
  • Increasing the price differential between generic and brand drug copays;
  • Combating the growing use of copay coupons offered by brand-name drug manufacturers with step therapy and other strategies;
  • Creating leaner formularies that feature fewer brand-name drugs; and
  • Launching comprehensive member and physician communication campaigns.

For more information or to order your copy today, please call 888-446-3530 or visit:

The report also features case studies from leading employers on how they achieved significant savings and improved generic dispensing rates through innovative programs aimed at promoting generics, plus exclusive data from AIS' quarterly survey of PBMs and related companies, on average ingredient cost, fill rates and more.

Order Benefit Design Tools to Take Full Advantage of the Wave of Generic Drugs today and get strategies to capitalize on this unprecedented flood of generic entries into the marketplace!

For a detailed table of contents or to order your copy today, please visit:

Please feel free to contact our customer service department with any questions you may have.

Warm Regards,

Melanie Matthews
Executive Vice President
The Healthcare Intelligence Network
800 State Highway 71
Suite 2
Sea Girt, NJ 08750

P.S. Please forward this news announcement to your colleagues who might
find it useful.